Added to YB: 2026-09-08
Pitch date: 2026-09-05
COV.V [neutral]
Covalon Technologies Ltd.
Author Info
I research and share thesis-driven ideas on potential healthcare multibaggers. Sign up for the newsletter.
Company Info
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally.
Market Cap
CAD 91.1M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
16.47
P/E
20.72
EV/Sales
2.14
Sector
Biotechnology
Category
growth
This Week in Healthcare - Issue #1 - Covalon Technologies Ltd.
COV.V (earnings): Covalon reported fiscal Q3 revenue growth of 20% year over year to $10.0 million, gross margin of 67.2% versus 46.5%, and adjusted EBITDA of $3.0 million versus $0.9 million. Contamination Protection revenue grew 68% and the US Vascular Access channel grew 51%. Cash increased $2.8 million over three months to $19.4 million, with no bank debt.
Read full article (1 min)